EUVIMEDEUVIMED entdecken
Crossref

Molecular Landscape, Genomic Shift, and Prediction in the Neoadjuvant Setting of Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Laura Pons, Laura Hernandez, Aintzane Urbizu, Laura Arnaldo, Paula Rodriguez-Martinez, Carolina Sanz, Ana M Muñoz-Mármol, Eva Fernandez, Eudald Felip, Vanesa Quiroga, Mireia Margelí, Pedro L Fernandez

Modern Pathology · 2025

DOI: 10.1016/j.modpat.2025.100787 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2025. Verfasst von Laura Pons und 11 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Germans Trias i Pujol, Pathology Department, Badalona, Barcelona, Spain; Germans Trias i Pujol Research Institute (IGTP), Badalona, Barcelon…. Hauptthemen laut MEDLINE: Breast Neoplasms, Erb-b2 Receptor Tyrosine Kinases, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Fundació la Marató de TV3, European Social Fund Plus, European Regional Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsErb-b2 Receptor Tyrosine KinasesBiomarkers, TumorHumansFemaleNeoadjuvant TherapyMiddle AgedAdultAgedTumor Suppressor Protein p53MutationHigh-Throughput Nucleotide Sequencing

Stichwörter der Autor:innen

breast cancerhuman epidermal growth factor receptor 2neoadjuvant therapyp53predictive biomarkers

Substanzen

Erb-b2 Receptor Tyrosine KinasesBiomarkers, TumorTumor Suppressor Protein p53ERBB2 protein, humanTP53 protein, human

Autor:innen und Institutionen

  • Hospital Germans Trias i Pujol, Pathology Department, Badalona, Barcelona, Spain; Germans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Spain.
  • Hospital Germans Trias i Pujol Medical, Oncology Department (ICO), Badalona, Barcelona, Spain; Badalona-Applied Research Group in Oncology (B-ARGO), Badalona, Barcelona, Spain.
  • Hospital Germans Trias i Pujol, Pathology Department, Badalona, Barcelona, Spain; Germans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Spain; Autonomous University of Barcelona, Barcelona, Spain. Electr…

Förderung

  • Fundació la Marató de TV3
  • European Social Fund Plus
  • European Regional Development Fund
  • Instituto de Salud Carlos III

Zitieren

APA

Pons, L., Hernandez, L., Urbizu, A., Arnaldo, L., Rodriguez-Martinez, P., Sanz, C., Muñoz-Mármol, A. M., Fernandez, E., Felip, E., Quiroga, V., Margelí, M., & Fernandez, P. L. (2025). Molecular Landscape, Genomic Shift, and Prediction in the Neoadjuvant Setting of Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer. Modern Pathology. https://doi.org/10.1016/j.modpat.2025.100787

Vancouver

Pons L, Hernandez L, Urbizu A, Arnaldo L, Rodriguez-Martinez P, Sanz C, et al. Molecular Landscape, Genomic Shift, and Prediction in the Neoadjuvant Setting of Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer. Modern Pathology. 2025. doi:10.1016/j.modpat.2025.100787

BibTeX
@article{Pons2025,
  author = {Pons, Laura and Hernandez, Laura and Urbizu, Aintzane and Arnaldo, Laura and Rodriguez-Martinez, Paula and Sanz, Carolina and Muñoz-Mármol, Ana M and Fernandez, Eva and Felip, Eudald and Quiroga, Vanesa and Margelí, Mireia and Fernandez, Pedro L},
  title = {Molecular Landscape, Genomic Shift, and Prediction in the Neoadjuvant Setting of Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer},
  journal = {Modern Pathology},
  year = {2025},
  doi = {10.1016/j.modpat.2025.100787}
}
Kostenlos starten →